Physiomics Share Discussion Threads

[share14] 04/1/2024 13:05

Why are you reposting an RNS from early November? Trying to make it look like something's happening here when it isn't and there's hardly any trades?

It's not due anything, and somebody doing chart analysis on a stock this size with hardly any volume is pointless.

[simonsmithiv] 04/1/2024 09:50

Everything getting very tight, could signal a sharp move soon. Aimho.


free stock charts from uk.advfn.com

[share14] 19/12/2023 14:59

"Wonder when the next one will be..."

About 45 minutes after that post

[share14] 19/12/2023 09:48

Blimey, there aren't several rampy Laura posts on lse and it's almost 10am. Unusual.

Looks like last weeks ramp accompanied by a steady stream of 500ish quid buys ran out of steam on its own accord. Wonder when the next one will be...

[criticalthinker1] 18/12/2023 17:57

I wonder if Physiomics has had any dealings with Wellcome sanger institute.....

[davevt] 17/12/2023 21:25

Someone tell Laura it doesn't matter if any 'news' is released in December, it's all part of the '1 million pipeline' she has kept flogging to death.

Already priced in to the current share price

[porky9] 17/12/2023 18:01

There is only the one declared TR1 holder with over 3% and that is:-
Gary Marshall At 3.32%

[share14] 12/12/2023 12:54

Just so happens to coincide with the usual crew turning up on the lse board

[5chipper] 12/12/2023 12:48

That’s all that one is able to buy!

[share14] 12/12/2023 12:32

Dave, have you noticed since the lse pumping began yesterday there's been a stream of piddly buys around 500 quid?

[davevt] 11/12/2023 16:50

I do like how they are trying to get excited and suggest December news may happen..

Er, December news is irrelevant now. In fact any further news until the financial year end is irrelevant They've already told us the 'pipeline' revenues in advance remember...so any news to come is part of that 1 million...it's already priced in.

In fact I can't believe pyc even told expected revenues in advance, it's totally counterproductive. Any new contract is already pre expected and factored in to that revenue quote.

[shortcpx] 11/12/2023 16:20

It was obvious from day 1. Laura is Riddler is a TR1 holder. Stig/stockz is the other one given they're the two main pumpers.

[blueball] 11/12/2023 16:03

Whats happening..

[davevt] 11/12/2023 15:03

Laura just let it slip they are riddler..

'
Look at other bio techs who trade on x 10 or x 50 annual revenues'

Remember how riddles used to constantly go on about irrelevant companies 'trading at x times revenues'..

[porky9] 10/12/2023 07:12

@davevt
In your considered opinion do you see a way of turning around this business?
You clearly know your stuff, did you work there or something?
I totally agree regarding buying in at the current price. There is no possible way this can reach BE point without another cash injection, at best it might be able to reduce the losses in the current year. So investing at 1.5p knowing a raise will follow is just plain nuts.
From the limited research I have carried out, as it stands they clearly need to diversify, employing staff on Biostats i don't think is enough in its own right? Also from the report it looks like they only have the one on sales, no marketing staff? which is probably why it cant get the exponential growth it needs?
Only just now having a CRM installed, what the hell have they been doing all this time.. I do question that.
Anyhow, i think there is potential here, just not yet and not in its current format which is why II won't touch it. They cant keep doing the same things and expecting a different outcome. IMO they need someone with solid business acumen on the board or at very least advisory?
I do actually like Jim, i have said before i think the guy is an honest broker but i don't know about anyone else when you watch the last review, with the new guy coughing in the background, its like watching some old BBC open university science discussion, zero enthusiasm.
Anyhow, interested to know how you think it could be changed for the better or is it a total lost cause?

[davevt] 07/12/2023 16:18

More irrelevant spam from kinghomerj about dosemerx.

His post clearly states precision dosing for *antibiotics*.

So, nothing to do with pyc.

[davevt] 06/12/2023 13:13

No one on here expected otherwise.

[jasonpugh] 06/12/2023 10:09

Looks like you guys will not be receiving 6% for Val 201. Val needs cash. Placing coming. 6p my estimate. 🤦‍a94;️. DYOR

[davevt] 05/12/2023 18:40

That's why pyc hardly gets any business. The big pharma do what pyc do in house, and for ALL types of drugs. Pyc only does dose prediction, and only for some cancer drugs.

[criticalthinker1] 04/12/2023 18:54

Pfizer re it's increased investment in ROI are lauding the future of AI in its drug development programmes.
All best Steadydanny

[davevt] 29/11/2023 10:02

Aberwystwyth 'They must think PYC are worth investment at a lower entry point'

Which means they don't think it's worth the investment at the current entry point.

Now he's getting it.

I mean, if it was worth say 10p, it wouldn't matter where people buy in right?

So well done to Aberwystwyth by finally recognizing this company is worth very little.

[terminator101] 28/11/2023 11:34

Morning gerbils. Does everyone understand big Jim's business model yet? 20 years of increasing expenses ahead of tiny revenue growth.